This new guide from the Washington Office on Latin America provides an analysis of women, drug policies and incarceration in Latin America and the Caribbean.
Using a case study approach, this article evaluates the results of a human rights-based advocacy approach on access to pain medicine and palliative care in India, Kenya, and Ukraine.
During eight months, the study monitored 539 drug users for their HCV-related risk behaviour in the four European countries/cities. The results are summarised in this report.
This OSF paper summarises elements of a growing consensus among international bodies on what constitutes good practice in drug prevention programmes. It also assesses some of the challenges of drawing lessons from the existing body of published work on the subject.
The discussion was grouped around five broad areas: demand reduction; supply reduction; new challenges; alternative development; and human rights. Out of the discussions as a whole, some key issues emerged as likely to be central to UNGASS 2016.
According to Harm Reduction International, introducing human rights-based indicators is the only way to ensure that drug policy works to promote the health and welfare of humankind by respecting, protecting and fulfilling international human rights obligations.
West African countries provided their inputs towards the contribution of Member States to the outcome document of the UN General Assembly Special Session.
